Evidence
J Neurol Sci. 2024 Aug 29;466:123203. doi: 10.1016/j.jns.2024.123203. Online ahead of print.
ABSTRACT
The clinical and neuropathological characteristics of progressive supranuclear palsy (PSP) with preservation of levodopa (L-dopa) response are described in this report. We present the case of a 73-year-old Japanese man with a 13-year history of dopa-responsive Parkinsonism and abnormalities observed in metaiodobenzylguanidine (MIBG) myocardial scintigraphy, suggesting Parkinson’s disease. However, autopsy results revealed PSP pathology, including tuft-shaped astrocytes and globose-type neurofibrillary tangles, without Lewy body pathology. The degeneration was moderately to severely distributed in the globus pallidus, subthalamic nucleus, and substantia nigra, whereas striatal degeneration was mild. These findings suggest an intact response to L-dopa therapy throughout the patient’s lifetime. Pathological examination of cardiac sympathetic nerves revealed intact nerves, suggesting functional involvement in the MIBG abnormality. This study provides further evidence of the clinical and pathological heterogeneity of PSP. Homozygosity for both the rs564309-C allele at TRIM11 and the rs2242367-G allele at SLC2A13 might have played a protective role. This case indicates a protracted course-PSP, which may hold promise for future treatments.
PMID:39260141 | DOI:10.1016/j.jns.2024.123203
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Long-standing preservation of levodopa response in progressive supranuclear palsy
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy
- Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
- "¿Cómo qué, cómo qué? cómo qué?" Single-language echolalia in a bilingual female with progressive supranuclear palsy: a case report
- The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy
- DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation
- Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study
- Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study
- Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease
- Clinical characteristics of Japanese patients with corticobasal degeneration
- Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia
- Behavioral and histological analyses of the mouse Bassoon p.P3882A mutation corresponding to the human BSN p.P3866A mutation
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
- Added value of FDG-PET for detection of progressive supranuclear palsy
- Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome
- Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
- GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate
- CSF Proteomics in Patients With Progressive Supranuclear Palsy
- CSF Proteomics in Patients With Progressive Supranuclear Palsy
- MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
- Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
- Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
- Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
- Corpus callosum damage in PSP and unsteady PD patients: A multimodal MRI study
- Tau protein profiling in tauopathies: a human brain study
- Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Multiple sclerosis in LRRK2 G2019S Parkinson's disease and isolated nigral degeneration in a homozygous variant carrier
- Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
- Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
- Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases
- Autopsy-Proven "Pure" Parkinson's Disease with Rapidly Progressive Dementia and Cognitive Fluctuations in a Patient with GBA Mutation
- Impact of motor dysfunction on neuropsychiatric symptom profile in patients with autopsy-confirmed Alzheimer's disease
- Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease
- Unfolded protein response markers Grp78 and eIF2alpha are upregulated with increasing alpha-synuclein levels in Lewy body disease
- Histopathological Investigation of Progressive Encephalomyelitis with Rigidity and Myoclonus: An Autopsy Case Characterized by Oculomotor Dysfunction and Autonomic Failure
- A Neuropathology Case Report of a Woman with Down Syndrome who Remained Cognitively Stable
- Evaluating the efficacy of few-shot learning for GPT-4Vision in neurodegenerative disease histopathology: A comparative analysis with convolutional neural network model
- A case of left posterior cortical atrophy presenting with kana-predominant reading impairment
- Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy
- Predictors of Care Home Admission and Survival Rate in Patients With Syndromes Associated With Frontotemporal Lobar Degeneration in Europe
- Synaptic changes in psychiatric and neurological disorders: state-of-the art of in vivo imaging
- Levodopa-responsive dystonia, parkinsonism, and treatment-resistant schizoaffective disorder in Williams syndrome
- Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning
- Candidate GRN Variant in Patient With Progressive Supranuclear Palsy
- The dopaminergic system promotes neprilysin-mediated degradation of amyloid-β in the brain
- TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy
- Pure argyrophilic grain disease revisited: independent effects on limbic, neocortical, and striato-pallido-nigral degeneration and the development of dementia in a series with a low to moderate Braak stage
- Astrocyte-Neuron Interactions in Alzheimer's Disease
- Genes for endosomal pH regulators NHE6 and NHE9 are dysregulated in the substantia nigra in parkinson's disease
- Therapeutic drug monitoring in Parkinson's disease
- Involvement of the nigrostriatal system in Gerstman-Sträussler-Scheinker disease with the PRNP-P102L mutation
- Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapy
- Factors associated with cognitive impairment before intracerebral haemorrhage: community-based neuropathological study
- Non-fluent Primary Progressive Aphasia and Its Association to Motor Neuron Disease
- Progressive Cerebrocerebellar Uncoupling in Sporadic and Genetic Forms of Amyotrophic Lateral Sclerosis
- Clinical, neuropathological, and molecular characteristics of rapidly progressive dementia with Lewy bodies: a distinct clinicopathological entity?
- Rapidly progressive myopathy: unveiling light Chain amyloidosis as an initial manifestation of multiple myeloma. A case report and literature review
- Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome
- Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease
- Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
- Brain perfusion SPECT in dementia: what radiologists should know
Evidence Blueprint
Long-standing preservation of levodopa response in progressive supranuclear palsy
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Long-standing preservation of levodopa response in progressive supranuclear palsy
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy
- Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy
- Corticobasal degeneration with visual hallucination as an initial symptom: A case report
- Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body Pathology
- Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
- Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants
- Astrocyte tau deposition in progressive supranuclear palsy is associated with dysregulation of MAPT transcription
- Impaired sequence manipulation in non-demented patients with progressive supranuclear palsy
- "¿Cómo qué, cómo qué? cómo qué?" Single-language echolalia in a bilingual female with progressive supranuclear palsy: a case report
- The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy
- The MAPT P.G324L and P.A406G mutations are associated with progressive supranuclear palsy with atypical features
- DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation
- Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study
- Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study
- Clinicopathologic and Neuroimaging Correlations of Nonverbal Oral Apraxia in Patients With Neurodegenerative Disease
- [18F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration
- Clinical characteristics of Japanese patients with corticobasal degeneration
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Subjective cognitive complaints in patients with progressive supranuclear palsy
- Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia
- Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
- Behavioral and histological analyses of the mouse Bassoon p.P3882A mutation corresponding to the human BSN p.P3866A mutation
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
- Added value of FDG-PET for detection of progressive supranuclear palsy
- Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome
- Neuropathologic findings in a patient with hemiparkinsonism and hemiatrophy syndrome
- Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy
- GPR37 processing in neurodegeneration: a potential marker for Parkinson's Disease progression rate
- Absolute quantitation of sympathetic nerve activity using [123I] metaiodobenzylguanidine SPECT-CT in neurology
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
- Pathology of neurodegenerative disease for the general neurologist
- Neuropathologic Validation and Diagnostic Accuracy of Presynaptic Dopaminergic Imaging in the Diagnosis of Parkinsonism
- Deep Learning-based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- The degeneration of locus coeruleus occurring during Alzheimer's disease clinical progression: a neuroimaging follow-up investigation
- CSF Proteomics in Patients With Progressive Supranuclear Palsy
- CSF Proteomics in Patients With Progressive Supranuclear Palsy
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases
- MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy
- Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- Progress in Primary Progressive Aphasia: A Review
- New knowledge on anti-IgLON5 disease
- Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
- Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
- Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS
- Case of Hallervorden-Spatz Syndrome: A Tale of Twin Sisters
- Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease
- Progressive Supranuclear palsy (PSP) disease progression, management, and healthcare resource utilization: a retrospective observational study in the US and Canada
- Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging
- Corpus callosum damage in PSP and unsteady PD patients: A multimodal MRI study
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
- Tau protein profiling in tauopathies: a human brain study
- Lateral geniculate body is spared of tau pathology in Pick disease
- Phase delays between mouse globus pallidus neurons entrained by common oscillatory drive arise from their intrinsic properties, not their coupling
- Conventional magnetic resonance imaging key features for distinguishing pathologically confirmed corticobasal degeneration from its mimics: a retrospective analysis of the J-VAC study
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer's disease
- Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology
- Reduced cardiac 123I-MIBG uptake is a robust biomarker of Lewy body disease in isolated rapid eye movement sleep behaviour disorder
- Tau in Atypical Parkinsonisms: A Meta-Analysis of in Vivo PET Imaging Findings